SCHEMBL1573088

SCHEMBL1573088

COc1c(C)c(C(=O)c2ccc(N)c(C(=O)O)c2)n2cc(OCCOCCOCCOCCOCCOCCOCCOc3ccc4c(OC)c(C)c(C(=O)c5ccc(N)c(C(=O)O)c5)n4c3)ccc12

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ RARB P10826 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ RARA P10276 1/20 0.33
▸ LMNA P02545 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ CNR1 P21554 1/20 0.32
▸ CNR2 P34972 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ CBX7 O95931 1/20 0.31
▸ PLA2G1B P04054 1/20 0.31
▸ PLA2G2A P14555 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1573145 1.00 RARB (0.34) RARBALDH1A1KMT2ARARALMNA
SCHEMBL1573232 0.93 ALDH1A1 (0.33) ALDH1A1KMT2ALMNAMAPTL3MBTL1
SCHEMBL4514569 0.92 MAPT (0.36) ALDH1A1KMT2ALMNAMAPTL3MBTL1
SCHEMBL4500669 0.91 LMNA (0.34) ALDH1A1KMT2ALMNAMAPTL3MBTL1
SCHEMBL3947583 0.89 ALDH1A1 (0.36) ALDH1A1KMT2AKDM4EHPGDTSHR
SCHEMBL1572762 0.87 SRD5A2 (0.39) ALDH1A1KMT2AKDM4ERAB9A
SCHEMBL4507759 0.84 KDM4E (0.36) ALDH1A1KMT2ALMNAMAPTCNR1
SCHEMBL4514573 0.84 PLA2G1B (0.32) RARBKMT2ARARAKDM4EPLA2G1B
SCHEMBL13918705 0.84 MAPT (0.35) ALDH1A1KMT2ALMNAMAPTL3MBTL1
SCHEMBL1573306 0.83 POLB (0.36) ALDH1A1KMT2ALMNAMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2018165-B1 FGF-PECEPTOR AGONIST DIMERIC COMPOUNDS SANOFI AVENTIS (FR) 2011-04-13 — — EP claimed
US-20090069368-A1 FGF-RECEPTOR AGONIST DIMERIC COMPOUNDS SANOFI-AVENTIS (FR) 2009-03-12 — — US claimed
US-9120819-B2 FGF-receptor agonist dimeric compounds SANOFI (FR) 2015-09-01 — — US disclosed
US-20090069368-A1 FGF-RECEPTOR AGONIST DIMERIC COMPOUNDS SANOFI-AVENTIS (FR) 2009-03-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069368-A1 FGF-RECEPTOR AGONIST DIMERIC COMPOUNDS FGF2, FGFR1, FGF1 RARB 445/4885ALDH1A1 1044/4885KMT2A 3395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback